Alvimopan: an oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction--a 21-day treatment-randomized clinical trial (Q33212983)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Alvimopan: an oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction--a 21-day treatment-randomized clinical trial |
scientific article |
Statements
1 reference
Alvimopan: an oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction--a 21-day treatment-randomized clinical trial (English)
1 reference
Daniel M Paulson
1 reference
Daniel T Kennedy
1 reference
Roger A Donovick
1 reference
Randall L Carpenter
1 reference
Maryann Cherubini
1 reference
Lee Techner
1 reference
Wei Du
1 reference
Yuju Ma
1 reference
William K Schmidt
1 reference
Bruce Wallin
1 reference
David Jackson
1 reference
1 March 2005
1 reference
1 reference
184-192
1 reference
Identifiers
1 reference
1 reference